Dainippon Sumitomo Pharma Acquires Boston Biomedical for $2,630,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9f565cfa-590f-4799-9763-c323f10712e5&Preview=1
Date
3/2/2012
Company Name
Boston Biomedical
Mailing Address
333 Providence Hwy. Norwood, MA 02062
Company Description
Boston Biomedical, Inc. is a privately held biotechnology company focusing on research and development of novel therapeutics to treat cancer.
Website
http://www.Bostonbiomedical.com
Transaction Type
M&A
Transaction Amount
$2,630,000,000
Transaction Round
Proceeds Purposes
M&A Terms
DSP will acquire BBI for up to $2.63 billion in total which includes $200 million upfront, up to $540 million in development milestone payments, and up to $1.89 billion in sales milestone payments.